Astra Industrial Group announces its Interim Financial Results for the Period Ending on 2022-06-30 ( Six Months )
| Element List | Current Quarter | Similar quarter for previous year | %Change | Previous Quarter | % Change |
|---|---|---|---|---|---|
| Sales/Revenue | 608,544,428 | 533,087,193 | 14.15 | 634,518,985 | -4.09 |
| Gross Profit (Loss) | 225,761,071 | 205,369,678 | 9.93 | 273,877,052 | -17.57 |
| Operational Profit (Loss) | 91,400,602 | 71,019,085 | 28.7 | 95,306,033 | -4.1 |
| Net Profit (Loss) after Zakat and Tax | 243,096,412 | 54,599,836 | 345.23 | 74,690,225 | 225.47 |
| Total Comprehensive Income | 238,228,033 | 48,500,974 | 391.18 | 74,723,664 | 218.81 |
| All figures are in (Actual) Saudi Arabia, Riyals | |||||
| Element List | Current Period | Similar period for previous year | %Change |
|---|---|---|---|
| Sales/Revenue | 1,243,063,413 | 1,127,633,052 | 10.24 |
| Gross Profit (Loss) | 499,638,123 | 463,381,862 | 7.82 |
| Operational Profit (Loss) | 186,706,635 | 188,226,158 | -0.81 |
| Net Profit (Loss) after Zakat and Tax | 317,786,637 | 105,205,604 | 202.06 |
| Total Comprehensive Income | 312,951,697 | 86,525,793 | 261.69 |
| Total Share Holders Equity (after Deducting Minority Equity) | 1,644,592,701 | 1,352,372,354 | 21.61 |
| Profit (Loss) per Share | 3.97 | 1.32 | |
| All figures are in (Actual) Saudi Arabia, Riyals | |||
| Element List | Explanation |
|---|---|
| The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is | Net profit increases in general due to:
1. Gain from discontinued operation
2. Increase in sales and gross profit in the following sectors:
a) Pharmaceuticals b) Specialty chemical |
| The reason of the increase (decrease) in the net profit during the current quarter compared to the previous quarter of the current year is | Net profit increases in general due to:
1. Gain from discontinued operation
2. Decrease in selling and distribution expenses in pharmaceuticals sector.
3. Decrease in general and administrative expenses in the following sectors:
a) Pharmaceuticals b) Specialty chemical c) Other
While noting that there is decrease in gross profit in the following sectors: a) Pharmaceuticals b) Specialty chemical c) Power and steel |
| The reason of the increase (decrease) in the net profit during the current period compared to the same period of the last year is | Net profit increases in general due to:
1. Gain from discontinued operation
2. Increase in sales and gross profit in the following sectors:
a) Pharmaceuticals b) Specialty chemical
3. Decrease in other expenses in pharmaceuticals sector.
4. Decrease in provision for impairment of financial assets in all sectors.
While noting that there is increase in selling and distribution expenses and general and administrative expenses in all sectors. |
| Statement of the type of external auditor's report | Unmodified conclusion |
| Reclassification of Comparison Items | Certain comparative figures for the previous period have been reclassified to be consistent with the presentation of the current period. |
| Additional Information | 1. Net Shareholders’ Equity at the end of the period was SR1,644,232,915/- compared to SR1,407,057,157/- at the end of the similar period last year with an increase of 17%.
2. With the completion of the sale of Al Anmaa during the period, the financial results and statements of Al Tanmiya were accounted for in accordance with IFRS requirements. Please refer to Note 13 of the condensed interim consolidated financial statements for further details. |
Comments